Commerce Bank’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,215
| Closed | -$216K | – | 1041 |
|
|
2020
Q2 | $216K | Buy |
+4,215
| New | +$216K | ﹤0.01% | 930 |
|
|
2019
Q2 | – | Sell |
-3,960
| Closed | -$203K | – | 929 |
|
|
2019
Q1 | $203K | Sell |
3,960
-672
| -15% | -$34.4K | ﹤0.01% | 847 |
|
|
2018
Q4 | $218K | Hold |
4,632
| – | – | ﹤0.01% | 794 |
|
|
2018
Q3 | $260K | Hold |
4,632
| – | – | ﹤0.01% | 781 |
|
|
2018
Q2 | $234K | Sell |
4,632
-630
| -12% | -$31.8K | ﹤0.01% | 799 |
|
|
2018
Q1 | $259K | Hold |
5,262
| – | – | ﹤0.01% | 752 |
|
|
2017
Q4 | $271K | Sell |
5,262
-180
| -3% | -$9.27K | ﹤0.01% | 746 |
|
|
2017
Q3 | $284K | Sell |
5,442
-45
| -0.8% | -$2.35K | ﹤0.01% | 716 |
|
|
2017
Q2 | $284K | Sell |
5,487
-150
| -3% | -$7.76K | ﹤0.01% | 701 |
|
|
2017
Q1 | $284K | Sell |
5,637
-1,065
| -16% | -$53.7K | ﹤0.01% | 693 |
|
|
2016
Q4 | $316K | Sell |
6,702
-120
| -2% | -$5.66K | ﹤0.01% | 634 |
|
|
2016
Q3 | $339K | Buy |
6,822
+72
| +1% | +$3.58K | 0.01% | 612 |
|
|
2016
Q2 | $325K | Sell |
6,750
-390
| -5% | -$18.8K | 0.01% | 621 |
|
|
2016
Q1 | $326K | Sell |
7,140
-540
| -7% | -$24.7K | 0.01% | 619 |
|
|
2015
Q4 | $414K | Sell |
7,680
-75
| -1% | -$4.04K | 0.01% | 544 |
|
|
2015
Q3 | $383K | Hold |
7,755
| – | – | 0.01% | 565 |
|
|
2015
Q2 | $451K | Sell |
7,755
-915
| -11% | -$53.2K | 0.01% | 552 |
|
|
2015
Q1 | $498K | Sell |
8,670
-300
| -3% | -$17.2K | 0.01% | 535 |
|
|
2014
Q4 | $453K | Sell |
8,970
-1,305
| -13% | -$65.9K | 0.01% | 557 |
|
|
2014
Q3 | $481K | Sell |
10,275
-150
| -1% | -$7.02K | 0.01% | 524 |
|
|
2014
Q2 | $470K | Buy |
10,425
+4,575
| +78% | +$206K | 0.01% | 536 |
|
|
2014
Q1 | $247K | Hold |
5,850
| – | – | ﹤0.01% | 692 |
|
|
2013
Q4 | $230K | Sell |
5,850
-450
| -7% | -$17.7K | ﹤0.01% | 701 |
|
|
2013
Q3 | $223K | Sell |
6,300
-1,500
| -19% | -$53.1K | ﹤0.01% | 689 |
|
|
2013
Q2 | $259K | Buy |
+7,800
| New | +$259K | ﹤0.01% | 634 |
|